In addition to metabolic disorders, estrogen deficiency elevates low-grade systematic inflammation, with increased levels of proinflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) as well as prostaglandins [4, 5]. This evidence concerns the gene TNF and metabolic disease.